Company intelligence / Profile preview

Clinglobal

Ownership: Private
Development stage: Commercial

Overview

Clinglobal provides preclinical and clinical research services for animal health products. It does not develop its own drugs but supports clients' product development through laboratory R&D, regulatory affairs consulting, quality assurance audits, field trials, and data sciences. The company operates globally with facilities in South Africa and Morocco and an expanded presence in Europe via acquisition of OCRvet. No direct clinical results or proprietary drug candidates reported.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeBiologicVaccineMonoclonal antibody
Industry: Contract Research Organization

Partnerships

Marshall BioResources joint venture via Clinvet USA LLC expansion in New York State

Beyond the preview

Go deeper on Clinglobal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinglobal.

Explore the full profile